Latest Cost Management News

Page 13 of 102
NZME Limited has upgraded its FY25 Operating EBITDA guidance, signaling stronger-than-expected financial performance despite economic headwinds. The company now expects earnings between $59 million and $62 million, up from its earlier forecast.
Elise Vega
Elise Vega
29 Oct 2025
ENRG Elements Limited has completed a $1.6 million entitlement offer while advancing a strategic review of its portfolio, including relinquishing Canadian lithium licenses and focusing on uranium and copper assets.
Maxwell Dee
Maxwell Dee
28 Oct 2025
Hydrix Limited reports a robust quarter with $3.35 million in sales, a 7% revenue increase, and a strong international client base, while advancing US market ventures.
Ada Torres
Ada Torres
28 Oct 2025
Jatcorp’s Q1 FY26 revenue dipped 8% following a record Q4, yet the company advanced key growth initiatives including Southeast Asia expansion and a leadership change.
Victor Sage
Victor Sage
28 Oct 2025
SOCO Corporation has returned to profitability in FY25, driven by strategic contract wins and client diversification. The company is now focusing on expanding recurring revenues and leveraging AI and cybersecurity capabilities for future growth.
Victor Sage
Victor Sage
28 Oct 2025
The Calmer Co has reported a robust 26% increase in quarterly sales, driven by strong growth in Australia and the US, alongside a significant 39% reduction in cash used in operations, signaling clear progress toward profitability.
Victor Sage
Victor Sage
28 Oct 2025
The Calmer Co. International Limited has delivered its strongest quarter yet, with revenue surging 26% to $2.4 million and operating cash outflows dropping to a historic low. Strategic growth across retail, e-commerce, and B2B channels underpins its confident path to breakeven.
Victor Sage
Victor Sage
28 Oct 2025
Microba Life Sciences reports robust Q1 FY26 growth in microbiome diagnostics, introduces workflow-enhancing features, and prepares for key therapeutic deal catalysts by year-end.
Ada Torres
Ada Torres
28 Oct 2025
Microba Life Sciences reports a 145% jump in core microbiome test volumes and is on track to achieve regional break-even by FY26, supported by strategic cost cuts and a $14.5 million capital raise.
Ada Torres
Ada Torres
28 Oct 2025
AdAlta Limited has made significant progress in its 'East to West' cellular immunotherapy strategy, advancing licensing negotiations for its first CAR-T product and raising $1.6 million through placements to bolster its financial position.
Ada Torres
Ada Torres
28 Oct 2025
Big River Industries reports a 4.9% sales decline year-to-date but highlights stabilizing revenue and resilient margins, with a cautious outlook on residential recovery and steady commercial demand.
Victor Sage
Victor Sage
28 Oct 2025
BetMakers Technology Group kicks off FY26 with a strong financial turnaround and strategic advances, including a promising acquisition and digital wagering expansion in Nevada.
Sophie Babbage
Sophie Babbage
28 Oct 2025